Navigation Links
Major Physician Group Issues Statement in Support of Physician/Industry Relationships
Date:5/15/2009

HOUSTON, May 15 /PRNewswire-USNewswire/ -- The American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE and ACE) today released a Position Statement on Physician/Industry Relationships. The position is a strong statement in support of continuing the beneficial and ethical collaboration between physicians and industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The statement, shown below in its entirety, was released at the AACE 18th Annual Meeting and Clinical Congress in Houston.

"The American Association of Clinical Endocrinologists and The American College of Endocrinology (AACE and ACE) believe that interaction between physicians and industry has contributed to safe, effective, and value- oriented health care. AACE and ACE affirm that relationships between physicians and industry have been overwhelmingly consistent with ethical standards and responsive to the needs of patients.

There is no inherent conflict of interest in the working relationship of physicians with industry and government. Rather, there is a commonality of interest that is healthy, desirable, and beneficial. The collaborative and constructive relationship among physicians, government, and industry has resulted in many medical advancements and improved health outcomes.

Since their inception, AACE and ACE have formulated policies and procedures to guide the conduct of the organizations and their members in cooperative interactions with industry and with government. These policies are continually being updated to reflect the changing practice and health care environment. AACE and ACE are committed to preserving relationships, including those with industry and with government, that contribute to the fulfillment of their basic mission: to enhance physicians' ability to provide the highest quality of medical care for patients with endocrine disorders."

-AACE and ACE Position Statement on Physician/Industry Relationships

May 15, 2009

"Physician and industry collaboration has advanced the treatment of major illnesses such as diabetes, heart disease, osteoporosis, high cholesterol and hypertension," said Daniel Duick, MD, FACP FACE, and President of the AACE. "The overwhelming majority of physicians, in all fields of healthcare, evaluate and apply advances that are deemed effective, safe and result in best clinical practice outcomes; and, they do so with their patients in mind, and not for pharmaceutical perks."

The Position Statement will be published in the May/June issue of Endocrine Practice, the Journal of the American Association of Clinical Endocrinologists.

To view a copy of the AACE and ACE policies and procedures regarding the disclosure of conflicts of interest, please click here.

For more information on the AACE 18th Annual Meeting and Clinical Congress, click here.

A short, one page bio and high resolution photo of AACE President Daniel Duick, MD, FACP, FACE, are available here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Laboratory at UI plays major role in diagnosing cancer
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. Major grant advances UWs clinical and translational research enterprise
7. Major differences revealed in how local authorities in the UK support disabled people
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
11. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology: